4//SEC Filing
Heerma Peter 4
Accession 0001789617-25-000007
CIK 0001438533other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:05 PM ET
Size
6.9 KB
Accession
0001789617-25-000007
Insider Transaction Report
Form 4
Heerma Peter
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Common Stock
2025-10-31$35.00/sh−5,591$195,685→ 119,071 total - Gift
Common Stock
2025-11-03−1,078→ 117,993 total
Footnotes (2)
- [F1]This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
- [F2]This transaction represents a charitable gift of 1,078 shares of common stock to a donor advised fund, which was gifted pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001789617
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:05 PM ET
- Size
- 6.9 KB